mothertobaby semaglutide fact sheet pregnancy 2024 Resources in Additional Languages Semaglutide pregnancy risks: Experts call

Kaiser Permanente Northwest, prior authorization criteria for GLP-1 anti-obesity agents California Medi-Cal dropped GLP-1 obesity coverage effective January 1, 2026, eliminating the weight-loss Wegovy pathway for Kaiser Medi-Cal members in California

Moreover, certain analyses have reported reductions in atrial fibrillation incidence among patients treated with GLP-1 therapies compared to other glucose-lowering agents

Another 2024 study said the weight loss benefits were similar between oral and injectable versions

By month 18, youve likely achieved most of what the medication will produce for you, and the focus shifts to maintenance